Dermazor
Product Images NDC 63302-202

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dermazor (NDC 63302-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prestigio Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

02

02
"DermaZor Psoriasis Medicated Skin Treatment" is a cream designed to relieve and prevent symptoms associated with psoriasis and seborrheic dermatitis, such as itching, irritation, flaking, redness, and dryness. It is formulated with a patented unique formula that includes 3% salicylic acid, zinc, and cannabis, which have been clinically approved and found to be safe for use on all skin types and all ages over 2 years old. The product is hypoallergenic, has no side effects, and can be applied to any part of the body, including intimate areas. It harnesses the healing powers of cannabis to help soothe and restore moisture to the skin while preventing recurrences of symptomatic outbreaks.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.